Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 128.61M P/E - EPS this Y -17.40% Ern Qtrly Grth -
Income -10.22M Forward P/E -14.30 EPS next Y -1.20% 50D Avg Chg -1.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -20.00%
Dividend N/A Price/Book 11.01 EPS next 5Y - 52W High Chg -53.00%
Recommedations 2.00 Quick Ratio 5.34 Shares Outstanding 13.14M 52W Low Chg 20.00%
Insider Own 52.92% ROA -72.45% Shares Float 5.93M Beta 3.30
Inst Own 7.93% ROE -123.67% Shares Shorted/Prior 505.18K/451.70K Price 10.01
Gross Margin - Profit Margin - Avg. Volume 20,577 Target Price 38.00
Oper. Margin - Earnings Date Oct 17 Volume 19,212 Change 1.21%
About Greenwich LifeSciences, Inc.

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.

Greenwich LifeSciences, Inc. News
GLSI Chatroom

User Image Waterwing Posted - 4 hours ago

$GLSI

User Image jeremy0916 Posted - 11 hours ago

$GLSI Decent adds here in November by some tutes. 87k shares with one.

User Image jeremy0916 Posted - 16 hours ago

$GLSI Surely they would not have this quiet period for nothing burger in December I feel like. It’s been kinda a quiet year for this stock outside the one move to 20 early in the year. I feel like they probably want to raise some money between now and eoy 2025, likely sooner rather than later. I wonder if Snehal could announce a BP partner at this stage too into the p3 they have entered agreements with that likes the data? Only other thing I think they could have some early quantifiable data on would be immune response data in controls vs placebo like they captured in the early months of the p2 they charted before. That could be given for a subset of the patients at SABCS eh?

User Image jeremy0916 Posted - 1 day ago

$GLSI Does a site in this state mean that it met its quota of desired patients?

User Image buffetthemuffet Posted - 1 day ago

$GLSI They are burning cash at the moment

User Image Gulfoil Posted - 1 day ago

$GLSI i didnt get the shares i wanted at $12.50:(

User Image Lets_Go_Brndn Posted - 1 day ago

@jeremy0916 @Alwaysdiversify 100% This is what we have been waiting for. $GLSI

User Image mshah1615 Posted - 1 day ago

$GLSI Anybody know who is attending London Healthcare Conference And are they presenting anything or looking How to raise funds

User Image mshah1615 Posted - 1 day ago

$GLSI what this mean Product manufactured in and exported from the U.S No They cancel “NO” But didn’t replace with anything

User Image Jizzle14 Posted - 1 day ago

$GLSI limit hit for 12.24 today! Ready to bounce now 🤑

User Image jeremy0916 Posted - 2 days ago

$GLSI We ready for some potential Jay T. / Snehal magic come December? Will they bring us a solid Christmas gift? Guess we will find out.

User Image Alwaysdiversify Posted - 2 days ago

$GLSI Anyone happen to notice that shares available to short shot up from 200K yesterday to 550K today? Highest amount in a long time. Ummm.

User Image doc123266 Posted - 2 days ago

$GLSI late day bump could be a little volume out of Jeffries.

User Image doc123266 Posted - 2 days ago

$GLSI any news out of the Jeffries conference ?

User Image Lukeing_At_Stocks Posted - 2 days ago

$GLSI Slingshot

User Image albert88 Posted - 2 days ago

$GLSI Back to 9 bounce again.

User Image TurdHunterSoda Posted - 3 days ago

$GLSI thanks for nothing RFK

User Image Alwaysdiversify Posted - 3 days ago

$GLSI Will dip no lower than $12. If it does, big bounce coming again.

User Image CjTrader1 Posted - 3 days ago

$GLSI why the selling?

User Image yft212 Posted - 3 days ago

$GLSI Greenwich LifeSciences Provides Update on Corporate Events The Company's planned upcoming events are listed below: Nov 19 - 21, 2024 – Jefferies London Healthcare Conference Dec 10 - 13, 2024 – San Antonio Breast Cancer Symposium (SABCS) Dec 19, 2024 – Annual Meeting of Stockholders Feb 10 - 11, 2025 – BIO CEO & Investor Conference Mar 6 - 7, 2025 – GBG Annual Scientific Meeting

User Image mshah1615 Posted - 6 days ago

$GLSI All this volume came from 13.15 to 12.80

User Image Alwaysdiversify Posted - 6 days ago

$GLSI This is slipping on dinky volume. Patel not buying only due to a lock out or the perception of bad optics with positive news likely near-term. Last chance before the train leaves the station.......

User Image Lukeing_At_Stocks Posted - 6 days ago

$GLSI Taking a non-scientific poll - How's everyone feeling about short term/long term here?

User Image mshah1615 Posted - 1 week ago

$GLSI I am very bullish on this stock but there is always risks please don’t hype too much On SABCS.I hope everything going according to the plan.CEO & Other insiders are silent.that is good news

User Image KINGSTOCKERS Posted - 1 week ago

$GLSI Poster Session 5 12:30 – 2:00 p.m. Friday, December 13

User Image Lets_Go_Brndn Posted - 1 week ago

$GLSI Next month. San Antonio. $100+ Look at the float. Snehal release the kraken and anyone who has this has the proverbial lot of gold at the end of the rainbow. No leprechauns needed.

User Image Lets_Go_Brndn Posted - 1 week ago

$CYBR CFO retiring. They said in the past no buy out. I don’t believe it. This is a company on the move with huge M&A potential from others deep pockets. Will add BIG after my $GLSI hits next month at SABCS. I see it over $50 and most likely over $100+ when Snehal releases data.

User Image hmjung1991 Posted - 1 week ago

$GLSI this may be a winner stock

User Image mshah1615 Posted - 1 week ago

$GLSI There is updates every week on this trial Guy like me it is hard to figure out what change Can somebody please start posting development When update get release Last Update Posted 2024-11-05

User Image hkjj Posted - 1 week ago

$GLSI A stock makes changing in our life

Analyst Ratings
HC Wainwright & Co. Buy Aug 23, 24
HC Wainwright & Co. Buy May 22, 24
HC Wainwright & Co. Buy Feb 28, 24
HC Wainwright & Co. Buy Feb 20, 24
HC Wainwright & Co. Buy Apr 10, 23
HC Wainwright & Co. Buy Sep 1, 21
Aegis Capital Buy Jan 27, 21
Aegis Capital Buy Jan 26, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Patel Snehal CEO and CFO CEO and CFO Nov 10 Buy 10.1675 5,000 50,838 5,312,677 11/14/23
Patel Snehal CEO and CFO CEO and CFO Nov 03 Buy 9.11 3,500 31,885 5,307,677 11/07/23
Thompson Jaye VP Clinical Reg Affa.. VP Clinical Reg Affairs Oct 27 Buy 8.57 500 4,285 260,348 10/31/23
Patel Snehal CEO and CFO CEO and CFO Oct 26 Buy 7.97 2,500 19,925 5,304,177 10/30/23
Patel Snehal CEO and CFO CEO and CFO Oct 25 Buy 7.91 2,500 19,775 5,301,677 10/27/23
Patel Snehal CEO and CFO CEO and CFO Oct 10 Buy 9.07 1,000 9,070 5,299,177 10/12/23
Patel Snehal CEO and CFO CEO and CFO Oct 04 Buy 8.63 2,000 17,260 5,298,177 10/05/23
Thompson Jaye VP Clinical Reg Affa.. VP Clinical Reg Affairs Sep 26 Buy 8.71 600 5,226 259,848 09/28/23
Patel Snehal CEO and CFO CEO and CFO Sep 19 Buy 8.95 4,000 35,800 5,296,177 09/21/23
Patel Snehal CEO and CFO CEO and CFO Sep 11 Buy 9.48 1,000 9,480 5,292,177 09/13/23
Patel Snehal CEO and CFO CEO and CFO Aug 22 Buy 9.97 1,000 9,970 5,291,177 08/24/23
Patel Snehal CEO and CFO CEO and CFO Aug 04 Buy 10.55 2,000 21,100 5,290,177 08/08/23
Patel Snehal CEO and CFO CEO and CFO Jul 21 Buy 9.20 1,000 9,200 5,288,177 07/25/23
Thompson Jaye VP Clinical Reg Affa.. VP Clinical Reg Affairs Jul 13 Buy 9.49 250 2,372 259,248 07/17/23
Patel Snehal CEO and CFO CEO and CFO May 17 Buy 11.69 1,000 11,690 5,287,177 05/18/23
Thompson Jaye VP Clinical Reg Affa.. VP Clinical Reg Affairs Apr 28 Buy 11.22 250 2,805 258,998 05/02/23
Patel Snehal CEO and CFO CEO and CFO Apr 19 Buy 11.10 7,000 77,700 5,286,177 04/21/23
Patel Snehal CEO and CFO CEO and CFO Apr 18 Buy 11.12 2,000 22,240 5,279,177 04/20/23
Thompson Jaye VP Clinical Reg Affa.. VP Clinical Reg Affairs Apr 11 Buy 11.87 1,000 11,870 258,745 04/12/23
Patel Snehal CEO and CFO CEO and CFO Apr 11 Buy 12.42 5,000 62,100 5,271,177 04/12/23
Thompson Jaye VP Clinical Reg Affa.. VP Clinical Reg Affairs Mar 15 Buy 12.71 250 3,178 257,745 03/16/23
Patel Snehal CEO and CFO CEO and CFO Mar 10 Buy 12.12 1,000 12,120 2,737,486 03/13/23
Thompson Jaye VP Clinical Reg Affa.. VP Clinical Reg Affairs Feb 24 Buy 15.395 250 3,849 257,495 02/28/23
Patel Snehal CEO and CFO CEO and CFO Feb 17 Buy 16.53 600 9,918 2,736,486 02/22/23
Patel Snehal CEO and CFO CEO and CFO Feb 10 Buy 18.68 1,000 18,680 2,735,886 02/14/23
Thompson Jaye VP Clinical Reg Affa.. VP Clinical Reg Affairs Feb 03 Buy 20.84 250 5,210 257,245 02/07/23
Patel Snehal CEO and CFO CEO and CFO Jan 27 Buy 19.35 2,000 38,700 2,734,886 01/31/23
Thompson Jaye VP Clinical Reg Affa.. VP Clinical Reg Affairs Jan 27 Buy 19.20 250 4,800 256,995 01/30/23
Patel Snehal CEO and CFO CEO and CFO Jan 20 Buy 17.37 1,500 26,055 2,732,886 01/24/23
Thompson Jaye VP Clinical Reg Affa.. VP Clinical Reg Affairs Jan 13 Buy 16.50 250 4,125 256,745 01/17/23
Patel Snehal CEO and CFO CEO and CFO Jan 06 Buy 15.18 1,500 22,770 2,731,386 01/10/23
Patel Snehal CEO and CFO CEO and CFO Dec 29 Buy 15.19 4,000 60,760 2,729,886 01/03/23
Patel Snehal CEO and CFO CEO and CFO Dec 16 Buy 13.01 1,000 13,010 2,725,886 12/20/22
Thompson Jaye VP Clinical Reg Affa.. VP Clinical Reg Affairs Dec 16 Buy 12.94 250 3,235 256,495 12/20/22
Patel Snehal CEO and CFO CEO and CFO Dec 09 Buy 13.11 2,000 26,220 2,724,886 12/13/22
Patel Snehal CEO and CFO CEO and CFO Dec 02 Buy 13.84 1,000 13,840 2,722,886 12/06/22
Thompson Jaye VP Clinical Reg Affa.. VP Clinical Reg Affairs Dec 02 Buy 13.98 250 3,495 256,245 12/06/22
Patel Snehal CEO and CFO CEO and CFO Nov 02 Buy 8.79 2,000 17,580 2,721,886 11/04/22
Patel Snehal CEO and CFO CEO and CFO Sep 30 Buy 9.46 1,000 9,460 2,714,886 10/04/22
Patel Snehal CEO and CFO CEO and CFO Sep 29 Buy 9.23 1,000 9,230 2,713,886 10/03/22
Patel Snehal CEO and CFO CEO and CFO Jun 24 Buy 9.13 29,000 264,770 2,712,886 06/27/22
Patel Snehal CEO and CFO CEO and CFO Jun 16 Buy 7.13 8,000 57,040 2,683,886 06/17/22
Patel Snehal CEO and CFO CEO and CFO Jun 14 Buy 7.91 12,000 94,920 2,675,886 06/15/22
Patel Snehal CEO and CFO CEO and CFO Jun 10 Buy 8.33 12,000 99,960 2,663,886 06/13/22
Patel Snehal CEO and CFO CEO and CFO Jun 09 Buy 10.90 4,500 49,050 1,243,453 06/10/22
Patel Snehal CEO and CFO CEO and CFO Jun 07 Buy 8.55 6,000 51,300 1,238,953 06/08/22
Patel Snehal CEO and CFO CEO and CFO Jun 03 Buy 8.35 9,250 77,238 1,232,953 06/06/22
Patel Snehal CEO and CFO CEO and CFO Jun 02 Buy 7.38 6,774 49,992 1,223,703 06/03/22
Daugherty Frank Joseph Chief Medical Office.. Chief Medical Officer Apr 25 Buy 16.25 1,000 16,250 90,121 04/26/22
Patel Snehal CEO and CFO CEO and CFO Apr 21 Buy 16.09 6,000 96,540 1,216,929 04/22/22